SpringWorks Therapeutics Inc (SWTX)
36.81
-0.56
(-1.50%)
USD |
NASDAQ |
Dec 24, 16:00
SpringWorks Therapeutics Free Cash Flow: -221.15M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | -1.352B |
| PTC Therapeutics Inc | -274.19M |
| Blueprint Medicines Corp | -250.52M |
| Edgewise Therapeutics Inc | -110.10M |
| NovaBay Pharmaceuticals Inc | -4.812M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.38M |
| Cash from Investing (Quarterly) | 28.65M |
| Cash from Financing (Quarterly) | 1.291M |
| Free Cash Flow Per Share (Quarterly) | -0.3666 |
| Free Cash Flow to Equity (Quarterly) | -27.23M |
| Free Cash Flow Yield | -8.36% |